Abstract
Background
Intramural metastasis (IM) is occasionally noted in patients with esophageal squamous cell carcinoma (ESCC). However, few recent studies have investigated the clinicopathological characteristics of IM and its survival impact. The present study aimed to clarify the clinicopathological and prognostic significance of IM in patients with ESCC.
Methods
We retrospectively examined 918 consecutive patients who underwent curative intent esophagectomy for ESCC. IM was defined as a pathologically confirmed metastatic lesion, which was clearly separate from the primary tumor and located within the esophageal or gastric wall. The clinicopathological characteristics and survival impact of IM were evaluated. A propensity score-matched analysis was performed to further elucidate the prognostic impact of IM.
Results
Among 918 patients, 46 (5.0%) had IM. Advanced tumors were significantly more frequent in patients with IM than in those without IM. The curative resection rate was lower in patients with IM (P = 0.001). Overall survival (OS) and disease-specific survival (DSS) were worse in patients with IM (both P < 0.001). In multivariate Cox proportional hazard analysis, IM presence was an independent poor prognostic indicator for OS and DSS (both P < 0.001). After propensity score matching, advanced tumors according to pathological N stage and lymphatic invasion were more frequent in patients with IM (P = 0.015 and 0.004, respectively). Additionally, OS and DSS were different between patients with and those without IM (both P = 0.002).
Conclusions
IM from ESCC is a local indicator of lymphatic invasion and advanced cancer, as well as an independent factor for poor prognosis.
Similar content being viewed by others
References
Takubo K, Sasajima K, Yamashita K et al (1990) Prognostic significance of intramural metastasis in patients with esophageal carcinoma. Cancer 65:1816–1819
Kato H, Tachimori Y, Watanabe H et al (1992) Intramural metastasis of thoracic esophageal carcinoma. Int J Cancer 50:49–52
Kuwano H, Watanabe M, Sadanaga N et al (1994) Univariate and multivariate analyses of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancer. J Surg Oncol 57:17–21
Nishimaki T, Suzuki T, Tanaka Y et al (1996) Intramural metastases from thoracic esophageal cancer: local indicators of advanced disease. World J Surg 20:32–37. https://doi.org/10.1007/s002689900006
Hokamura N, Kato H, Tachimori Y et al (2000) Preoperative chemotherapy for esophageal carcinoma with intramural metastasis. J Surg Oncol 75:117–121
Yuasa N, Miyake H, Yamada T et al (2004) Prognostic significance of the location of intramural metastasis in patients with esophageal squamous cell carcinoma. Langenbecks Arch Surg 389:122–127
Hashimoto T, Arai K, Yamashita Y et al (2013) Characteristics of intramural metastasis in gastric cancer. Gastric Cancer 16:537–542
Moon DH, Jeon JH, Yang HC et al (2018) Intramural metastasis as a risk factor for recurrence in esophageal squamous cell carcinoma. Ann Thorac Surg 106:249–256
Kuwano H, Nishimura Y, Oyama T et al (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus 12:1–30
Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74
Kuwano H, Nishimura Y, Ohtsu A et al (2008) Guidelines for diagnosis and treatment of carcinoma of the esophagus: April 2007 edition: part I edited by the Japan Esoplageal Society. Esophagus 5:61–73
Kuwano H, Nishimura Y, Ohtsu A et al (2008) Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part II edited by the Japan Esophageai Society. Esophagus 5:117–132
International Union Against Cancer (2017) In: Brierley JDGM, Wittekind C (eds) TNM classification of malignant tumors, 8th edn. Wiley, Oxford
Watson W (1933) Carcinoma of the esophagus. Surg Gynecol Obstet 56:884–897
Okamura A, Watanabe M, Mine S et al (2017) Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma. Dis Esophagus 30:1–8
Hara H, Tahara M, Daiko H et al (2013) Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma. Cancer Sci 104:1455–1460
Watanabe M, Baba Y, Yoshida N et al (2014) Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer. Ann Surg Oncol 21:2838–2844
Shiraishi O, Yamasaki M, Makino T et al (2017) Feasibility of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil versus adriamycin, cisplatin, and 5-fluorouracil for resectable advanced esophageal cancer. Oncology 92:101–108
Yang H, Liu H, Chen Y et al (2018) Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 36:2796–2803
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Okamura, A., Watanabe, M., Kozuki, R. et al. Significance of Intramural Metastasis in Patients with Esophageal Squamous Cell Carcinoma: An Indicator of Aggressive Cancer Behavior. World J Surg 43, 1997–2005 (2019). https://doi.org/10.1007/s00268-019-05004-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-019-05004-z